Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
Status:
Unknown status
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
This randomized phase III trial is to compare simultaneous modulated accelerated boost with
standard dose radiotherapy given together with chemotherapy in treating patients with
esophageal squamous cell carcinoma.